Investment Q&A

Q: Jim Chanos has expressed the opinion that NBIS and CRWV are capital intensive, low margin, and high risk investments. Your comments much appreciated. Thanks.

Q: Hello Team,

Considering the facts that:
Lumentum (LITE) is the High-Alpha play. It has the most momentum and the most critical technology (OCS), but it is currently considered "high risk/high reward" due to its vertical price chart.

Coherent (COHR) is the Catch-up play. It is favored by analysts who see "underappreciated upside." If Coherent can prove it is winning a larger share of the 1.6T transceiver market in its next earnings call (early 2026), its stock could "gap up" to match Lumentum's valuation.

For a 10 year investment, would you prioritize one over another? Or would you buy both?

Thank you for help all of us become richer and more informed in 2025. I wish you all at 5i a merry holiday season and a happy 2026. :)

Q: I am seeing sell recommendations for ARM from other analysts. ARM designs the CPUs used in almost all cellphones, the current Apple computers and a growing share of data centres. How could this stock be overvalued? What is your projection for the medium to long term?

Q: your choice for upside in this tech market today and why

Thanks Dave

Q: ASML or MPWR?

Q: I am considering adding AVGO with its most recent price decline on what appeared to be a good Q. Would you concur that the sell off has been over done given there was little to complain about in the quarterly release. MSFT is my other add consideration, as it has corrected some, likely in sympathy with the AI fears. Of the 2 which would you consider more attractive for a 5 year hold? In the account I also hold NVDA, GOOGL, META, AMZN, and MU for tech names. Thank you.
John

Q: Your thoughts please on the quarter released this week? Markets seemed to like ir?

Thx

Q: Greetings 5i, which companies do you consider to be NBIS's closest competitors? Out of this "peer group" how many of them do you think it is necessary to own to reap the benefits from exposure to the industry? Thank you.

Q: Peter; Not a question- re Grahams on DND - this is also a nice example of “ why not to average down” .
Rod

Q: Analysis of results - market seems to love it - has not been a favored stock for you - time to add here?

Q: CLS: heading down - still very high P.E., very high price to C.F. etc. Selling due in part to profit taking for year-end? Lofty price going into 2026 of $600.00 per share? Buy for TFSA 100 shares? Risk vs potential as I do not follow this one and know very little about tech.

Q: First and foremost Season's greatings and thank you very much for the support.

Following up on Joel's question from December 15th. I agree that subsidiaries will seek to integrate the use of AI into their processes in order to maintain and perhaps ultimately improve their margins, but this will have a direct impact on short-term profitability (e.g., one year). How can Constellation justify the multiple they are currently supporting with declining margins? The only way I see to improve profits would be to substantially increase accretive acquisitions during the transition. For my part, Constellation was my largest position and has lost a lot of value, even though I'm still up 200%. I'm really worried about what to do with my investment. How many quarters do you think I should wait before knowing more?


Thanks for your help.

Yves

Q: What should your members be looking for with the CSU family of stocks that the worst is over, Are there technical signs volume washouts or other signs the market negativity is declining?

Thx

Q: Few days ago I asked about DIS.
Now please provide your view on Netflix, with or without the WB deal and what sort of impact it would have on the stock in both outcomes

Q: AI related spending/margin concerns have hit the market over past week and CLS has declined to below $400, again.

Any concerns ? Do you still expect the stock to trade to $500 over 12-18 months ?

Is it safe to add now or wait for a further pull back ?

Thanks

Q: Good morning,

SE's downward trend continues and I'm contemplating a sell. I noticed that 5i has not had any questions on it since late October and I'm wondering about your current thoughts. If I choose to replace it, can you give me any three high conviction stock ideas that you feel may have strong momentum or bounce potential from current prices (any sector). Thank you. Brad

Q: Hello, I invested in the ETF BUG about a year ago. I had compared it to HACK and thought that BUG was more a pure play on cybersecurity than HACK, which has AVGO, NOC and GD as top 10 holdings (AVGO at #1 with 12%). After a year, BUG has barely moved whereas HACK has moved over 10%, probably because of the 3 stocks I mentioned. To what extend these 3 stocks belong in a cybersecurity ETF? If so, should I switch to HACK? Do you believe these 3 stocks will still perform very well in the years ahead? I have plenty of NVDA, so it was never my intention to buy AVGO on its own. Thanks.

Q: Hello 5i!

I have held VRT for 2.5 years and done well and have a full position in it. It has drifted lower as AI waffles around and other AI related players get more attention.
Do you see VRT as a “must own” for the space or do you have another stock in this space with more momentum and growth potential?

Also, Would you endorse selling a half position of VRT to buy ENS?

Sending all you fine folks at 5i the warmest wishes for the holidays. Thank you for all of your guidance throughout the years. It is appreciated. Enjoy some time off!

Q: These 2 stocks have done really well.

5i reccommended TSAT in a recent portfolio update and is now approx $6 higher than when you recommended it. Moved nicely on the govt contract news etc. My question here is what would you reccommend to enter this stock. A) Buy it at market now, B) Average in 1/3 at a time C) Sell an April 30 put at approx $3.5? or D) just wait out the volatility and buy it at a stink price between 25 and 30?

Secondly on a Tom Lee podcast he waxed eloquent about SATS and told listeners that if they don't own it go and buy it. Doesn't do that often with individual stocks. What is your opinion of SATS, it has really come a long way too this year. Would you consider it a buy?

With many thanks

Sheldon

Q: High level and subjective question about CSU. They historically bought mature slow growth SASS businesses with very little organic growth. Now the market perceives a risk that AI will disrupt their businesses. CSU will need to innovate rapidly to meet this challenge, BUT, CSU does not have a culture of innovation. Do you think CSU can rapidly become innovative at scale when that is so far from their core competency? Do they have the DNA to innovate AI into their businesses?

Thanks.